News

Zacks Investment Research on MSN3h
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when United Therapeutics (UTHR) reports results for the quarter ended March 2025. While this widely-known consensus outlook ...
Fintel on MSN1d
B of A Securities Upgrades United Therapeutics (UTHR)
Fintel reports that on April 21, 2025, B of A Securities upgraded their outlook for United Therapeutics (NasdaqGS:UTHR) from ...
United Therapeutics upgraded to Neutral at BofA following selloff
As previously reported, BofA analyst Jason Gerberry upgraded United Therapeutics (UTHR) to Neutral from Underperform with an unchanged price ...
United Therapeutics upgraded to Neutral from Underperform at BofA
BofA upgraded United Therapeutics (UTHR) to Neutral from Underperform with a $314 price target Stay Ahead of the Market: Discover ...